CONMED
CNMD
233 hedge funds and large institutions have $3.77B invested in CONMED in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 94 increasing their positions, 79 reducing their positions, and 31 closing their positions.
21% more capital invested
Capital invested by funds: $3.12B → $3.77B (+$657M)
19% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 79
1.67% more ownership
Funds ownership: 117.4% → 119.07% (+1.7%)
10% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 31
3% less funds holding
Funds holding: 239 → 233 (-6)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
71% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $37M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$31.4M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
+$30.3M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$20.2M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$18M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$17.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$36.5M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$28.3M |
| 3 |
Morgan Stanley
New York
|
-$21.2M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$20.3M |
| 5 |
LIP
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
|
-$9.59M |
CNMD Hedge Fund Activity: Q1 2023 in Review
233 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2023, worth a combined $3.77B — up 21% from $3.12B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of CNMD and 28 opened new positions — a net loss of 3 holders — while 79 trimmed existing stakes and 94 added.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $31.4M. The largest seller was Citadel Advisors, cutting an estimated $36.5M.
- 233 institutional investors held CONMED (CNMD) as of Q1 2023, down from 239 in Q4 2022.
- Funds reported $3.77B of CONMED stock for Q1 2023, up 21% quarter-over-quarter.
- 28 funds opened new CONMED positions in Q1 2023 and 31 closed out, a net change of -3 holders.
- The largest CONMED buyer in Q1 2023 was Camber Capital Management, an estimated $31.4M added.
- The largest CONMED seller in Q1 2023 was Citadel Advisors, an estimated $36.5M sold.
Based on aggregated 13F filings for Q1 2023.